Mtor Inhibition is Most Beneficial after Liver Transplantation for Hepatocellular Carcinoma in Patients with Active Tumors

Andreas A. Schnitzbauer,Natalie Filmann,Rene Adam,Philippe Bachellier,Wolf O. Bechstein,Thomas Becker,Sherrie Bhoori,Itxarone Bilbao,Jens Brockmann,Patrizia Burra,Olivier Chazouilleres,Umberto Cillo,Michele Colledan, Christoph Duvoux,Tom M. Ganten,Jean Gugenheim,Michael Heise,Bart van Hoek,Neville Jamieson,Koert P. de Jong,Christian G. Klein,Jurgen Klempnauer,Norman Kneteman,Jan Lerut,Heikki Makisalo,Vincenzo Mazzaferro,Darius F. Mirza,Silvio Nadalin,Peter Neuhaus, George-Philippe Pageaux,Antonio D. Pinna, Jaques Pirenne,Johann Pratschke, James Powel,Markus Rentsch,Magnus Rizell,Giorgio Rossi,Lionel Rostaing,Andre Roy,Tim Scholz,Utz Settmacher,Thomas Soliman,Simone Strasser,Gunnar Soderdahl,Roberto I. Troisi,Victor Sanchez Turrion,Hans J. Schlitt,Edward K. Geissler

Annals of Surgery（2020）

Cited 79|Views106
No score
Key words
AFP,Milan criteria,mTOR-inhibition,multivariate COX regression,Sirolimus
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined